Copyright
©The Author(s) 2025.
World J Gastroenterol. May 14, 2025; 31(18): 105729
Published online May 14, 2025. doi: 10.3748/wjg.v31.i18.105729
Published online May 14, 2025. doi: 10.3748/wjg.v31.i18.105729
Figure 4 Chaperonin-containing tailless complex polypeptide 1 subunit 6A affects the autophagy pathway in colorectal cancer cells.
A and B: Cell lysates were extracted from knockout (KO)-Control (Ctrl) and KO-chaperonin-containing tailless complex polypeptide 1 subunit 6A (CCT6A) HT29 cells, as well as overexpression (OE)-Ctrl and OE-CCT6A SW480 cells, and then subjected to immunoblotting using the indicated antibodies; C: Following treatment with chloroquine diphosphate salt (CQ, 20 μM, hereafter unless otherwise indicated) for 2 hours, immunoblotting was performed with the total proteins extracted from the indicated cells. DDP: Cisplatin; LC3: Light chain 3; mTOR: Mammalian target of rapamycin; Ulk1: Unc-51-like autophagy activating kinase 1.
- Citation: Ma JX, Li XJ, Li YL, Liu MC, Du RH, Cheng Y, Li LJ, Ai ZY, Jiang JT, Yan SY. Chaperonin-containing tailless complex polypeptide 1 subunit 6A negatively regulates autophagy and protects colorectal cancer cells from cisplatin-induced cytotoxicity. World J Gastroenterol 2025; 31(18): 105729
- URL: https://www.wjgnet.com/1007-9327/full/v31/i18/105729.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i18.105729